Related references
Note: Only part of the references are listed.Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
Taynah I. P. David et al.
SCIENTIFIC REPORTS (2020)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Induction of Oxidants Distinguishes Susceptibility of Prostate Carcinoma Cell Lines to p53 Gene Transfer Mediated by an Improved Adenoviral Vector
Rodrigo Esaki Tamura et al.
HUMAN GENE THERAPY (2017)
Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids
Arianna Fumagalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
Aline Hunger et al.
CELL DEATH & DISEASE (2017)
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F. V. Medrano et al.
ONCOTARGET (2017)
Exploiting the p53 Pathway for Therapy
Chit Fang Cheok et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
Aline Hunger et al.
CELL DEATH DISCOVERY (2017)
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy
Rodrigo Esaki Tamura et al.
CANCER BIOLOGY & THERAPY (2016)
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy
Ruan Felipe Vieira Medrano et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma
Joao Paulo Portela Catani et al.
TRANSLATIONAL ONCOLOGY (2016)
Sequential cancer mutations in cultured human intestinal stem cells
Jarno Drost et al.
NATURE (2015)
p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation
Xiao-Lan Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo
C. A. Merkel et al.
CANCER GENE THERAPY (2013)
Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts- Secreted Interferon Beta
Shalom Madar et al.
PLOS ONE (2013)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Development of an adenoviral vector with robust expression driven by p53
Marcio C. Bajgelman et al.
VIROLOGY (2008)
A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers
Henry H. Peng et al.
ANALYTICAL BIOCHEMISTRY (2006)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer
Y Sasaki et al.
GENE THERAPY (2001)